Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/88090
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study |
| Author: | Groen, H. Sistema, H. Vincent, A. Hochstenbag, M. van Putten, J. van den Berg, A. Dalesio, O. Biesma, B. Smit, H. Termeer, A. Hiltermann, T. van den Borne, B. Schramel, F. |
| Citation: | Journal of Clinical Oncology, 2011; 29(32):4320-4326 |
| Publisher: | American Society of Clinical Oncology |
| Issue Date: | 2011 |
| ISSN: | 0732-183X 1527-7755 |
| Statement of Responsibility: | Harry J.M. Groen, Hannie Sietsma, Andrew Vincent, Monique M.H. Hochstenbag, John W.G. van Putten, Anke van den Berg, Otilia Dalesio, Bonne Biesma, Hans J.M. Smit, Ariën Termeer, T. Jeroen N. Hiltermann, Ben E.E.M. van den Borne and Franz M.N.H. Schramel |
| Abstract: | Abstract not available |
| Keywords: | Humans Carcinoma, Non-Small-Cell Lung Lung Neoplasms Sulfonamides Taxoids Carboplatin Pyrazoles Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Quality of Life Adult Aged Aged, 80 and over Middle Aged Female Male Cyclooxygenase 2 Biomarkers, Tumor Celecoxib Docetaxel |
| Rights: | © 2011 by American Society of Clinical Oncology |
| DOI: | 10.1200/JCO.2011.35.5214 |
| Published version: | http://dx.doi.org/10.1200/jco.2011.35.5214 |
| Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.